SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-326750
Filing Date
2020-12-28
Accepted
2020-12-28 06:15:28
Documents
4
Period of Report
2020-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d23292d8k.htm 8-K 24734
2 EX-10.1 d23292dex101.htm EX-10.1 52680
3 EX-10.2 d23292dex102.htm EX-10.2 6357
4 EX-10.3 d23292dex103.htm EX-10.3 6912
  Complete submission text file 0001193125-20-326750.txt   91924
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 201414490
SIC: 2834 Pharmaceutical Preparations